Penserra Capital Management LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 178 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$89
-15.2%
28,284
+33.6%
0.00%0.0%
Q2 2023$105
+18.0%
21,175
+16.9%
0.00%0.0%
Q1 2023$89
+7.2%
18,110
+37.0%
0.00%0.0%
Q4 2022$83
-100.0%
13,220
-23.5%
0.00%
-60.0%
Q3 2022$186,000
+195.2%
17,272
+211.8%
0.01%
+150.0%
Q2 2022$63,000
-4.5%
5,540
-23.9%
0.00%0.0%
Q1 2022$66,000
-20.5%
7,276
+123.5%
0.00%0.0%
Q3 2021$83,0000.0%3,255
+1.1%
0.00%0.0%
Q2 2021$83,000
-25.9%
3,220
+1.3%
0.00%0.0%
Q1 2021$112,000
+38.3%
3,180
-1.9%
0.00%0.0%
Q4 2020$81,000
+84.1%
3,240
+172.7%
0.00%0.0%
Q3 2020$44,0001,1880.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders